The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Damaj Bassam since year 2005.
The trader's CIK number is 1478733.
At the time of this reporting, Damaj Bassam is the President and CEO of Innovus Pharmaceuticals, Inc. .
(stock ticker symbol INNV).
See this page for all insider trading activities at Innovus Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2013-06-12||INNV||Innovus Pharmaceuticals, Inc.||Buy||416,841||.32||134,639|
|2013-02-02||INNV||Innovus Pharmaceuticals, Inc.||Buy||250,406||.48||118,942|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Damaj Bassam (President and CEO of Innovus Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.